,,ii  #aafth ,,congress  #ast ,session  
,s4 #addh  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #ad1      
#bjai,mr4 ,markey 7for himself1 ,mr4    
,braun1 and ,mr4 ,manchin7 introduced   
the following bill2 which was read twice
 and referred to the ,committee on      
,health1 ,education1 ,labor1 and        
,pensions  ,a ,,bill  ,to require       
certain practitioners authorized to     
prescribe controlled substances to      
complete continuing education4  #a4     
,short title ,this ,act may be cited as 
the ,safer ,prescribing of ,controlled  
,substances ,act4  #b4 ,continuing      
education requirements for certain      
practitioners prescribing controlled    
substances ,section #cjc of the         
,controlled ,substances ,act 7#ba       
,u4,s4,c4 #hbc7 is amended-- 7#a7 in    
subsection 7f71 in the matter preceding 
paragraph 7#a71 by striking ,the        
,attorney ,general shall register and   
inserting ,subject to subsection 7k71   
the ,attorney ,general shall register2  

7#b7 by redesignating subsection 7k7 as 
subsection 7l72 and  7#c7 by inserting  
after subsection 7j7 the following3  7k7
 7#a7 ,in this subsection1 the term     
covered practitioner means a            
practitioner that is not a hospital1    
pharmacy1 or veterinarian4  7#b7 ,as a  
condition of granting or renewing the   
registration of a covered practitioner  
under this part to dispense1 or conduct 
research with1 controlled substances in 
schedule ,,ii1 ,,iii1 ,,iv1 or ,v1 the  
,attorney ,general shall require the    
covered practitioner to complete        
training through accredited continuing  
prescriber education that the ,secretary
 of ,health and ,human ,services        
determines meets the requirements under 
paragraph 7#c71 unless the covered      
practitioner meets the conditions       
described in paragraph 7#f74  7#c7 ,the 
training provided for purposes of       
paragraph 7#b7 shall1 at a minimum1     
expose covered practitioners to-- 7,a7  
best practices for pain management1     

including responsible prescribing of    
pain medications1 alternatives to       
prescribing controlled substances and   
other alternative therapies to decrease 
the use of opioids2  7,b7 tools to      
manage adherence and diversion of       
controlled substances1 including        
prescription drug monitoring programs1  
drug screening1 informed consent1       
overdose education1 and the use of      
opioid overdose antagonists2 and  7,c7  
best practices for substance use        
disorder treatment1 including methods   
for diagnosing1 treating1 and managing a
 substance use disorder1 including the  
use of medications approved by the ,food
 and ,drug ,administration and          
evidence-based nonpharmacological       
therapies1 and linking patients to      
evidence-based treatment for substance  
use disorders4  7#d7 ,the ,substance    
,abuse and ,mental ,health ,services    
,administration shall establish or      
support the establishment of not less   
than #a training module that meets the  

requirements under paragraph 7#c7 that  
is provided-- 7,a7 to any covered       
practitioner registered or applying for 
a registration under this part to       
dispense1 or conduct research with1     
controlled substances in schedule ,,ii1 
,,iii1 ,,iv1 or ,v2  7,b7 online2 and   
7,c7 free of charge4  7#e7 ,the         
,secretary of ,health and ,human        
,services shall establish1 maintain1 and
 periodically update a publically       
available database providing information
 relating to training modules that meet 
the requirements under paragraph 7#c74  
7#f7 ,a covered practitioner shall be   
deemed as completing the training       
described in paragraph 7#b7 if the      
covered practitioner completes          
accredited continuing prescriber        
education1 that-- 7,a7 is required1 as a
 condition of ,state practice licensure1
 to fulfill mandated training or        
education related to best practices in  
pain management and substance use       
disorder treatment1 that is             

substantially similar to the            
requirements described in paragraph     
7#c72 or  7,b7 is required1 as a        
condition of maintaining a board        
certification recognized by the         
appropriate board certification         
organizations for the covered prescriber
 to fulfill mandated training or        
education related to best practices in  
pain management and substance use       
disorder treatment1 that is             
substantially similar to the requirement
 described in paragraph 7#c74  7#g7 ,not
 later than #e years after the date of  
enactment of the ,safer ,prescribing of 
,controlled ,substances ,act1 the       
,secretary of ,health and ,human        
,services shall evaluate1 and make      
publically available a report           
describing1 how exposure to the training
 required under this subsection has     
changed prescribing patterns of         
controlled substances4  4